Comments on NASDAQ Rulemaking

Self-Regulatory Organizations; The Nasdaq Stock Market LLC; Notice of Filing of Proposed Rule Change to Adopt a New Continued Listing Requirement

Comments have been received from individuals and entities using a variety of Letter Types:

Comment
A: 261
B: 7
C: 9

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment David A. Donohoe, Jr., DonohoeAdvisoryAssociates, LLC
Public Comment Marc Indeglia, The Small Public Company Coalition
Public Comment Michael Messinger, Chief Financial Officer, SeaStar Medical
Public Comment Sullivan & Worcester LLP
Public Comment Anthony Diamandis
Public Comment Brian L. Ross, Partner, Graubard Miller
Public Comment David R. Burton, Senior Research Fellow, Advancing American Freedom
Public Comment James Foster, Chief Executive Officer, Virax Biolabs Group Limited
Public Comment John Zecca, EVP and Chief Legal Officer, The Nasdaq Stock Market LLC
Public Comment Maggie Schroeder
Public Comment Stephen John Berger, Managing Director, Global Head of Government and Regulatory Policy, Citadel Securities
Public Comment Anonymous
Public Comment Marc Indeglia, The Small Public Company Coalition
Public Comment Ravi Chandra Gaddan
Public Comment Trena Hedges
Public Comment Venkatachalam GS
Public Comment Cody Healey-Conelly
Public Comment David Danovitch, Angela Gomes, Brendan O’Brien and Phillip Carnevale, Sullivan & Worcester LLP
Public Comment Devin M. Laskowski
Public Comment Katie Kolchin, CFA Managing Director, Head of Equity & Options Market Structure, and Gerald O’Hara Vice President & Assistant General Counsel, SIFMA
Public Comment Dustin
Public Comment Rondeep Paul
Public Comment Eirik Møgedal
Public Comment Kyle Warren
Public Comment J. R.
Public Comment Ian Johnson
Public Comment Joanna Mallers, Secretary, PTG
Public Comment R. Cromwell Coulson, President and CEO, OTC Markets Group Inc.
Public Comment Subroto Mukerji
Public Comment Andrew Simpson, Chief Executive Officer, HeartSciences, Inc.

Last Reviewed or Updated: Feb. 6, 2026

File Number
SR-NASDAQ-2026-004
Release Number
34-104688
Related Materials
How to submit comments